Boston Partners’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5M Buy
+293,809
New +$16.8M 0.01% 419
2023
Q2
Sell
-361,259
Closed -$17.6M 733
2023
Q1
$17.6M Buy
361,259
+26,324
+8% +$1.16M 0.02% 321
2022
Q4
$23M Buy
334,935
+19,217
+6% +$1M 0.03% 287
2022
Q3
$20.1M Buy
+315,718
New +$15.1M 0.03% 295
2020
Q1
Sell
-240,621
Closed -$5.64M 716
2019
Q4
$5.64M Sell
240,621
-2,192
-0.9% -$46.9K 0.01% 369
2019
Q3
$5.58M Sell
242,813
-3,421
-1% -$78.3K 0.01% 378
2019
Q2
$6.32M Sell
246,234
-612,251
-71% -$19.1M 0.01% 403
2019
Q1
$31.1M Buy
+858,485
New +$29.4M 0.04% 283

Other funds holding OVV

Boston Partners's OVV Position: Q2 2026 in Review

Boston Partners opened a new position in Ovintiv (OVV) in Q2 2026: 293,809 shares worth $15.5M. The stake represents 0.01% of the portfolio and ranks #419 among its holdings. This is a return to the name: Boston Partners previously reported a position in OVV as recently as Q1 2023.

Boston Partners first reported a position in OVV in Q1 2019 and has held it in 8 quarters since. The position peaked at $31.1M in Q1 2019. 593 funds tracked by Wall St. Rank hold OVV as of Q2 2026.

  • Boston Partners held 293,809 shares of Ovintiv worth $15.5M as of Q2 2026.
  • Ovintiv was a new Boston Partners position in Q2 2026.
  • Ovintiv made up 0.01% of Boston Partners's portfolio in Q2 2026, its #419 holding.
  • Boston Partners first reported a position in Ovintiv in Q1 2019 and has held it in 8 quarters since.
  • Boston Partners's Ovintiv position peaked at $31.1M in Q1 2019.
  • 593 funds tracked by Wall St. Rank held Ovintiv as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.